GILD

Gilead Sciences
D

GILD

111.800
USD
0.65
(0.58%)
Pre Open
Volume
3,402
EPS
8
Div Yield
2.77
P/E
293
Market Cap
139,229,689,732
OverviewSignalsIdeasNews
Related Instruments
ABBV
ABBV
2.500
(1.23%)
205.150 USD
AMGN
AMGN
1.25
(0.41%)
306.95 USD
BIIB
BIIB
-1.870
(-1.33%)
138.460 USD
BMY
BMY
1.120
(1.90%)
60.010 USD
GSK
GSK
0.235
(0.61%)
38.750 USD
JNJ
JNJ
0.580
(0.36%)
163.690 USD
MRK
MRK
1.630
(1.86%)
89.230 USD
PFE
PFE
0.175
(0.70%)
25.190 USD
REGN
REGN
2.46
(0.39%)
637.72 USD
More
News
Treasury Yields Decline as Market Anticipates Fed Rate Cuts

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

7 months ago
Economy News
Novo Nordisk Surges in Profit and Sales

Novo Nordisk Surges in Profit and Sales

10 months ago
Stocks News
More

Title: Gilead Sciences

Sector: Healthcare
Industry: Drug Manufacturers - General
Gilead Sciences Inc. is an American biopharmaceutical firm that was founded in 1987 under the name Oligogen by Michael L. Riordan. The company specializes in the research, development and sale of medicines in underdeveloped research areas. To this end, the company engages its research in such areas as the human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under many brand names, including Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Sovaldi and more. The company is headquartered in Foster, California, and its stock is measured on the NASDAQ Biotechnology Index and the S&P 500 Index.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.